NM_016239.4:c.6052G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_016239.4(MYO15A):​c.6052G>A​(p.Gly2018Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.143 in 1,581,876 control chromosomes in the GnomAD database, including 20,908 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.16 ( 2502 hom., cov: 33)
Exomes 𝑓: 0.14 ( 18406 hom. )

Consequence

MYO15A
NM_016239.4 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 1.25

Publications

37 publications found
Variant links:
Genes affected
MYO15A (HGNC:7594): (myosin XVA) This gene encodes an unconventional myosin. This protein differs from other myosins in that it has a long N-terminal extension preceding the conserved motor domain. Studies in mice suggest that this protein is necessary for actin organization in the hair cells of the cochlea. Mutations in this gene have been associated with profound, congenital, neurosensory, nonsyndromal deafness. This gene is located within the Smith-Magenis syndrome region on chromosome 17. Read-through transcripts containing an upstream gene and this gene have been identified, but they are not thought to encode a fusion protein. Several alternatively spliced transcript variants have been described, but their full length sequences have not been determined. [provided by RefSeq, Jul 2008]
MYO15A Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=9.0833855E-5).
BP6
Variant 17-18143875-G-A is Benign according to our data. Variant chr17-18143875-G-A is described in ClinVar as Benign. ClinVar VariationId is 45754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.491 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYO15ANM_016239.4 linkc.6052G>A p.Gly2018Arg missense_variant Exon 28 of 66 ENST00000647165.2 NP_057323.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYO15AENST00000647165.2 linkc.6052G>A p.Gly2018Arg missense_variant Exon 28 of 66 NM_016239.4 ENSP00000495481.1

Frequencies

GnomAD3 genomes
AF:
0.159
AC:
24172
AN:
152100
Hom.:
2495
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.148
Gnomad AMI
AF:
0.0768
Gnomad AMR
AF:
0.262
Gnomad ASJ
AF:
0.112
Gnomad EAS
AF:
0.508
Gnomad SAS
AF:
0.169
Gnomad FIN
AF:
0.181
Gnomad MID
AF:
0.0854
Gnomad NFE
AF:
0.116
Gnomad OTH
AF:
0.155
GnomAD2 exomes
AF:
0.192
AC:
37975
AN:
198172
AF XY:
0.181
show subpopulations
Gnomad AFR exome
AF:
0.150
Gnomad AMR exome
AF:
0.356
Gnomad ASJ exome
AF:
0.111
Gnomad EAS exome
AF:
0.508
Gnomad FIN exome
AF:
0.172
Gnomad NFE exome
AF:
0.112
Gnomad OTH exome
AF:
0.155
GnomAD4 exome
AF:
0.141
AC:
201600
AN:
1429658
Hom.:
18406
Cov.:
38
AF XY:
0.141
AC XY:
99713
AN XY:
708132
show subpopulations
African (AFR)
AF:
0.144
AC:
4739
AN:
32910
American (AMR)
AF:
0.340
AC:
13465
AN:
39554
Ashkenazi Jewish (ASJ)
AF:
0.114
AC:
2922
AN:
25576
East Asian (EAS)
AF:
0.495
AC:
19060
AN:
38480
South Asian (SAS)
AF:
0.158
AC:
13039
AN:
82358
European-Finnish (FIN)
AF:
0.174
AC:
8819
AN:
50736
Middle Eastern (MID)
AF:
0.0856
AC:
491
AN:
5738
European-Non Finnish (NFE)
AF:
0.118
AC:
129667
AN:
1095072
Other (OTH)
AF:
0.159
AC:
9398
AN:
59234
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
13261
26523
39784
53046
66307
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5078
10156
15234
20312
25390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.159
AC:
24186
AN:
152218
Hom.:
2502
Cov.:
33
AF XY:
0.168
AC XY:
12482
AN XY:
74422
show subpopulations
African (AFR)
AF:
0.147
AC:
6125
AN:
41536
American (AMR)
AF:
0.263
AC:
4023
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.112
AC:
387
AN:
3470
East Asian (EAS)
AF:
0.507
AC:
2617
AN:
5164
South Asian (SAS)
AF:
0.167
AC:
804
AN:
4826
European-Finnish (FIN)
AF:
0.181
AC:
1917
AN:
10616
Middle Eastern (MID)
AF:
0.0918
AC:
27
AN:
294
European-Non Finnish (NFE)
AF:
0.116
AC:
7884
AN:
67986
Other (OTH)
AF:
0.157
AC:
332
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1002
2004
3006
4008
5010
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
252
504
756
1008
1260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.130
Hom.:
7021
Bravo
AF:
0.167
TwinsUK
AF:
0.117
AC:
434
ALSPAC
AF:
0.113
AC:
434
ESP6500AA
AF:
0.137
AC:
566
ESP6500EA
AF:
0.115
AC:
967
ExAC
AF:
0.157
AC:
18807
Asia WGS
AF:
0.299
AC:
1039
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
May 09, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

May 07, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Gly2018Arg in Exon 28 of MYO15A: This variant is not expected to have clinical s ignificance because it has been identified in 13.7% (472/3448) of African Americ an chromosomes from a broad population by the NHLBI Exome Sequencing Project (ht tp://evs.gs.washington.edu/EVS; dbSNP rs2272571). -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Autosomal recessive nonsyndromic hearing loss 3 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.063
BayesDel_addAF
Benign
-0.62
T
BayesDel_noAF
Benign
-0.51
CADD
Benign
7.8
DANN
Benign
0.73
DEOGEN2
Benign
0.0022
T;T;T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.0070
N
LIST_S2
Benign
0.52
T;.;T
MetaRNN
Benign
0.000091
T;T;T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
-1.7
.;N;N
PhyloP100
1.3
PrimateAI
Uncertain
0.51
T
PROVEAN
Benign
3.1
.;N;.
REVEL
Benign
0.17
Sift
Benign
1.0
.;T;.
Sift4G
Benign
1.0
T;T;.
Polyphen
0.0
.;B;B
Vest4
0.059
MutPred
0.23
Gain of helix (P = 0.0425);Gain of helix (P = 0.0425);Gain of helix (P = 0.0425);
ClinPred
0.00029
T
GERP RS
2.7
Varity_R
0.029
gMVP
0.22
Mutation Taster
=95/5
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2272571; hg19: chr17-18047189; COSMIC: COSV52753045; COSMIC: COSV52753045; API